Literature DB >> 27634302

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

Giorgio Oliviero1, Gerard L Brien2,3, Ariane Waston1, Gundula Streubel3, Emilia Jerman3, Darrell Andrews1, Benjamin Doyle1, Nayla Munawar1, Kieran Wynne1, John Crean1, Adrian P Bracken3, Gerard Cagney4.   

Abstract

Polycomb proteins assemble to form complexes with important roles in epigenetic regulation. The Polycomb Repressive Complex 2 (PRC2) modulates the di- and tri-methylation of lysine 27 on histone H3, each of which are associated with gene repression. Although three subunits, EZH1/2, SUZ12, and EED, form the catalytic core of PRC2, a wider group of proteins associate with low stoichiometry. This raises the question of whether dynamic variation of the PRC2 interactome results in alternative forms of the complex during differentiation. Here we compared the physical interactions of PRC2 in undifferentiated and differentiated states of NTERA2 pluripotent embryonic carcinoma cells. Label-free quantitative proteomics was used to assess endogenous immunoprecipitation of the EZH2 and SUZ12 subunits of PRC2. A high stringency data set reflecting the endogenous state of PRC2 was produced that included all previously reported core and associated PRC2 components, and several novel interacting proteins. Comparison of the interactomes obtained in undifferentiated and differentiated cells revealed candidate proteins that were enriched in complexes isolated from one of the two states. For example, SALL4 and ZNF281 associate with PRC2 in pluripotent cells, whereas PCL1 and SMAD3 preferentially associate with PRC2 in differentiating cells. Analysis of the mRNA and protein levels of these factors revealed that their association with PRC2 correlated with their cell state-specific expression. Taken together, we propose that dynamic changes to the PRC2 interactome during differentiation may contribute to directing its activity during cell fate transitions.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27634302      PMCID: PMC5098042          DOI: 10.1074/mcp.M116.062240

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  54 in total

1.  Dynamic protein-protein interaction wiring of the human spliceosome.

Authors:  Anna Hegele; Atanas Kamburov; Arndt Grossmann; Chrysovalantis Sourlis; Sylvia Wowro; Mareike Weimann; Cindy L Will; Vlad Pena; Reinhard Lührmann; Ulrich Stelzl
Journal:  Mol Cell       Date:  2012-02-24       Impact factor: 17.970

2.  JmjC-domain-containing proteins and histone demethylation.

Authors:  Robert J Klose; Eric M Kallin; Yi Zhang
Journal:  Nat Rev Genet       Date:  2006-09       Impact factor: 53.242

Review 3.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

4.  PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming.

Authors:  Zhuo Zhang; Amanda Jones; Chiao-Wang Sun; Chao Li; Chia-Wei Chang; Heui-Yun Joo; Qian Dai; Matthew R Mysliwiec; Li-Chen Wu; Yahong Guo; Wei Yang; Kaimao Liu; Kevin M Pawlik; Hediye Erdjument-Bromage; Paul Tempst; Youngsook Lee; Jinrong Min; Tim M Townes; Hengbin Wang
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

5.  Proteasome allostery as a population shift between interchanging conformers.

Authors:  Amy M Ruschak; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

6.  Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.

Authors:  Jiro Kikuchi; Daisuke Koyama; Taeko Wada; Tohru Izumi; Peter O Hofgaard; Bjarne Bogen; Yusuke Furukawa
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

Review 7.  Role of PRC2-associated factors in stem cells and disease.

Authors:  Pedro Vizán; Malte Beringer; Cecilia Ballaré; Luciano Di Croce
Journal:  FEBS J       Date:  2014-10-25       Impact factor: 5.542

8.  Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation.

Authors:  Gerard L Brien; Guillermo Gambero; David J O'Connell; Emilia Jerman; Siobhán A Turner; Chris M Egan; Eiseart J Dunne; Maike C Jurgens; Kieran Wynne; Lianhua Piao; Amanda J Lohan; Neil Ferguson; Xiaobing Shi; Krishna M Sinha; Brendan J Loftus; Gerard Cagney; Adrian P Bracken
Journal:  Nat Struct Mol Biol       Date:  2012-11-18       Impact factor: 15.369

9.  Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.

Authors:  Andrei Kuzmichev; Thomas Jenuwein; Paul Tempst; Danny Reinberg
Journal:  Mol Cell       Date:  2004-04-23       Impact factor: 17.970

10.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

View more
  23 in total

Review 1.  Targeting the epigenome in malignant pleural mesothelioma.

Authors:  Kaitlin C McLoughlin; Andrew S Kaufman; David S Schrump
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 2.  Epigenetic Factors in Schizophrenia: Mechanisms and Experimental Approaches.

Authors:  Melanie Föcking; Benjamin Doyle; Nayla Munawar; Eugene T Dillon; David Cotter; Gerard Cagney
Journal:  Mol Neuropsychiatry       Date:  2019-02-15

3.  Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells required for self-renewal.

Authors:  Gundula Streubel; Darren J Fitzpatrick; Giorgio Oliviero; Andrea Scelfo; Bruce Moran; Sudipto Das; Nayla Munawar; Ariane Watson; Kieran Wynne; Gian Luca Negri; Eugene T Dillon; SriGanesh Jammula; Karsten Hokamp; Darran P O'Connor; Diego Pasini; Gerard Cagney; Adrian P Bracken
Journal:  EMBO J       Date:  2017-05-29       Impact factor: 11.598

4.  The N-terminal methyltransferase homologs NRMT1 and NRMT2 exhibit novel regulation of activity through heterotrimer formation.

Authors:  Jon D Faughn; William L Dean; Christine E Schaner Tooley
Journal:  Protein Sci       Date:  2018-09-24       Impact factor: 6.725

5.  NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.

Authors:  Yiannis Drosos; Jacquelyn A Myers; Beisi Xu; Kaeli M Mathias; Emma C Beane; Sandi Radko-Juettner; Robert J Mobley; Margaret E Larsen; Federica Piccioni; Xiaotu Ma; Jonathan Low; Baranda S Hansen; Samuel T Peters; Natarajan V Bhanu; Sandeep K Dhanda; Taosheng Chen; Santhosh A Upadhyaya; Shondra M Pruett-Miller; David E Root; Benjamin A Garcia; Janet F Partridge; Charles W M Roberts
Journal:  Mol Cell       Date:  2022-05-09       Impact factor: 19.328

Review 6.  Unravelling the biology of chromatin in health and cancer using proteomic approaches.

Authors:  Cassandra G Eubanks; Gerald Dayebgadoh; Xingyu Liu; Michael P Washburn
Journal:  Expert Rev Proteomics       Date:  2017-09-20       Impact factor: 3.940

7.  Distinct PRC2 subunits regulate maintenance and establishment of Polycomb repression during differentiation.

Authors:  Ana Petracovici; Roberto Bonasio
Journal:  Mol Cell       Date:  2021-04-21       Impact factor: 19.328

Review 8.  A Structural Perspective on Gene Repression by Polycomb Repressive Complex 2.

Authors:  Xin Liu
Journal:  Subcell Biochem       Date:  2021

9.  miR302 regulates SNAI1 expression to control mesangial cell plasticity.

Authors:  L De Chiara; D Andrews; A Watson; G Oliviero; G Cagney; J Crean
Journal:  Sci Rep       Date:  2017-02-14       Impact factor: 4.379

10.  Live-cell imaging reveals the dynamics of PRC2 and recruitment to chromatin by SUZ12-associated subunits.

Authors:  Daniel T Youmans; Jens C Schmidt; Thomas R Cech
Journal:  Genes Dev       Date:  2018-06-11       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.